Page last updated: 2024-10-27

fluorouracil and Prostatic Diseases

fluorouracil has been researched along with Prostatic Diseases in 1 studies

Fluorouracil: A pyrimidine analog that is an antineoplastic antimetabolite. It interferes with DNA synthesis by blocking the THYMIDYLATE SYNTHETASE conversion of deoxyuridylic acid to thymidylic acid.
5-fluorouracil : A nucleobase analogue that is uracil in which the hydrogen at position 5 is replaced by fluorine. It is an antineoplastic agent which acts as an antimetabolite - following conversion to the active deoxynucleotide, it inhibits DNA synthesis (by blocking the conversion of deoxyuridylic acid to thymidylic acid by the cellular enzyme thymidylate synthetase) and so slows tumour growth.

Prostatic Diseases: Pathological processes involving the PROSTATE or its component tissues.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Belitsky, P1
Elhilali, MM1
Oliver, JA1

Other Studies

1 other study available for fluorouracil and Prostatic Diseases

ArticleYear
Effect of stilbestrol on the isoenzymes of lactate dehydrogenase in benign and malignant prostatic tissue.
    The Journal of urology, 1970, Volume: 104, Issue:3

    Topics: Antineoplastic Agents; Cyclophosphamide; Dactinomycin; Depression, Chemical; Diethylstilbestrol; Est

1970